XMTR Form 144: Insider Plans Sale of 9,331 Shares ($489K)

Xometry, Inc. (XMTR) insider sale notice: the filer intends to sell 9,331 shares of common stock on or about 10/02/2025, with an aggregate market value of $489,410.95 and 49,339,037 shares outstanding referenced for this class.

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) insider sale notice: the filer intends to sell 9,331 shares of common stock on or about 10/02/2025, with an aggregate market value of $489,410.95 and 49,339,037 shares outstanding referenced for this class. The shares were acquired as RSUs on 10/01/2025 and are reported as payable/transferable on 10/01/2025. The filing also discloses a prior sale by the same person on 07/02/2025 of 9,332 shares for $302,227.09. The broker listed for the proposed sale is UBS Financial Services Inc., 11 Madison Avenue, New York, NY, and the securities exchange is Nasdaq. The filer signs a standard representation that they are unaware of undisclosed material adverse information.

Positive

• None.

Negative

• Planned sale of 9,331 shares on 10/02/2025 with aggregate value $489,410.95
• Prior sale of 9,332 shares on 07/02/2025 for $302,227.09

Insights

Corporate Insider Transactions Analyst

Insider proposes near-term sale of 9,331 RSU shares valued at $489,410.95.

The filing reports a planned sale on 10/02/2025 through UBS of 9,331 common shares that were acquired as RSUs on 10/01/2025. This is a routine Form 144 notice required when insiders plan to sell restricted securities.

The same insider previously sold 9,332 shares on 07/02/2025 for $302,227.09, indicating multiple transactions in the recent period. The filing includes the standard certification that the seller is not aware of undisclosed material adverse information. No additional financial performance or company-specific disclosures are included in this notice.

FAQ

What does the XMTR Form 144 disclose about the proposed sale?

The filing states a proposed sale of 9,331 common shares on or about 10/02/2025, with aggregate market value $489,410.95, to be brokered by UBS Financial Services on Nasdaq.

When were the shares to be sold acquired according to the filing?

The filing shows the 9,331 shares were acquired as RSUs on 10/01/2025 and payment/date of acquisition is recorded as 10/01/2025.

Has this insider sold shares of XMTR recently?

Yes. The filer reported a prior sale on 07/02/2025 of 9,332 shares for $302,227.09.

Who is the broker named for the proposed sale in the Form 144?

The broker listed is UBS Financial Services Inc., 11 Madison Avenue, 4th Floor, New York, NY 10010.

Does the Form 144 include any statements about undisclosed material information?

Yes. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001869814
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Xometry, Inc.
SEC File Number	001-40546
Address of Issuer	6116 EXECUTIVE BOULEVARD, SUITE 800 NORTH BETHESDA MARYLAND 20852
Phone	240-335-7914
Name of Person for Whose Account the Securities are To Be Sold	Altschuler Randolph
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	9331	489410.95	49339037	10/02/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	RSU	Issuer			9331	10/01/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Randolph Altschuler c/o 6116 Executive Blvd Suite 800 North Bethesda MD 20852	Common	07/02/2025	9332	302227.09

144: Remarks and Signature

Remarks
Date of Notice	10/02/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/21/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Randolph Altschuler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)